SCHEMBL6570012

SCHEMBL6570012

CCCCN1CCC(NC(=O)c2ccc(Nc3c(C(=O)NC4CCN(Cc5ccccc5)CC4)cnc4c(OC)cccc34)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A12 P48065 2/20 0.53
▸ MCHR1 Q99705 3/20 0.52
▸ SIGMAR1 Q99720 2/20 0.48
▸ PRKAA2 P54646 2/20 0.48
▸ ACHE P22303 2/20 0.48
▸ BCHE P06276 1/20 0.48
▸ PRKAB2 O43741 1/20 0.47
▸ PRKAG1 P54619 1/20 0.47
▸ PRKAA1 Q13131 1/20 0.47
▸ PRKAG3 Q9UGI9 1/20 0.47
▸ PRKAG2 Q9UGJ0 1/20 0.47
▸ PRKAB1 Q9Y478 1/20 0.47
▸ TMEM97 Q5BJF2 1/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ JAK2 O60674 1/20 0.46
▸ JAK1 P23458 1/20 0.46
▸ TYK2 P29597 1/20 0.46
▸ JAK3 P52333 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9145344 1.00 SLC6A12 (0.53) SLC6A12MCHR1SIGMAR1PRKAA2ACHE
SCHEMBL9140781 0.95 SLC6A12 (0.58) SLC6A12MCHR1SIGMAR1PRKAA2ACHE
SCHEMBL6573538 0.94 SLC6A12 (0.55) SLC6A12MCHR1SIGMAR1PRKAA2ACHE
SCHEMBL6571119 0.93 SLC6A12 (0.54) SLC6A12MCHR1SIGMAR1PRKAA2ACHE
SCHEMBL9140021 0.92 SLC6A12 (0.51) SLC6A12MCHR1SIGMAR1PRKAA2ACHE
SCHEMBL9140098 0.91 SLC6A12 (0.55) SLC6A12MCHR1SIGMAR1PRKAA2ACHE
SCHEMBL9137922 0.91 SLC6A12 (0.48) SLC6A12MCHR1SIGMAR1PRKAA2ACHE
SCHEMBL9138847 0.90 DRD4 (0.58) SLC6A12MCHR1SIGMAR1PRKAA2ACHE
SCHEMBL9141810 0.90 DRD4 (0.54) SLC6A12MCHR1SIGMAR1PRKAA2ACHE
SCHEMBL9140774 0.90 KMT2A (0.59) SLC6A12MCHR1SIGMAR1PRKAA2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952346-A INHIBITS THE ACTIONS OF THE ALZHEIMER'S PROTEIN AMYLOID (BETA/A4) IN ISOLATED ENDOTHELIAL CELLS; QUINOLINE DERIVATIVES HOECHST MARION ROUSSEL DEUTSCHLAND GMBH (DE) 1999-09-14 — — US claimed
US-5438064-A For suppressing the binding of bradykinins to pain receptors AMERICAN HOME PRODUCTS CORPORATION (US) 1995-08-01 — — US claimed
EP-0835659-B1 Use of non-peptidic bradykinin antagonists in the preparation of medicaments for the treatment and prevention of Alzheimer's disease AVENTIS PHARMA GMBH (DE) 2004-12-15 — — EP disclosed
EP-0808628-B1 Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof HOECHST AG (DE) 2000-02-02 — — EP disclosed
EP-0835659-A1 Use of non-peptidic bradykinin antagonists in the preparation of medicaments for the treatment and prevention of Alzheimer's disease Hoechst Marion Roussel Deutschland GmbH (DE) 1998-04-15 — — EP disclosed
EP-0808627-A2 Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-26 — — EP disclosed
EP-0808628-A2 Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-26 — — EP disclosed
US-5438064-A For suppressing the binding of bradykinins to pain receptors AMERICAN HOME PRODUCTS CORPORATION (US) 1995-08-01 — — US disclosed
Send feedback